173 related articles for article (PubMed ID: 25091310)
1. Association between recent use of proton pump inhibitors and nontyphoid salmonellosis: a nested case-control study.
Wu HH; Chen YT; Shih CJ; Lee YT; Kuo SC; Chen TL
Clin Infect Dis; 2014 Dec; 59(11):1554-8. PubMed ID: 25091310
[TBL] [Abstract][Full Text] [Related]
2. Association between use of proton pump inhibitors and non-typhoidal salmonellosis identified following investigation into an outbreak of Salmonella Mikawasima in the UK, 2013.
Freeman R; Dabrera G; Lane C; Adams N; Browning L; Fowler T; Gorton R; Peters T; Mather H; Ashton P; Dallman T; Godbole G; Tubin-Delic D; Charlett A; Fisher I; Adak GK
Epidemiol Infect; 2016 Apr; 144(5):968-75. PubMed ID: 26424497
[TBL] [Abstract][Full Text] [Related]
3. Proton-Pump Inhibitor Use and the Risk of First-Time Ischemic Stroke in the General Population: A Nationwide Population-Based Study.
Wang YF; Chen YT; Luo JC; Chen TJ; Wu JC; Wang SJ
Am J Gastroenterol; 2017 Jul; 112(7):1084-1093. PubMed ID: 28397874
[TBL] [Abstract][Full Text] [Related]
4. Association between use of proton pump inhibitors and occurrence of colon diverticulitis.
Ho BL; Hu HY; Chang SS
J Chin Med Assoc; 2016 Jan; 79(1):5-10. PubMed ID: 26404898
[TBL] [Abstract][Full Text] [Related]
5. Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study.
Tsai CF; Chen MH; Wang YP; Chu CJ; Huang YH; Lin HC; Hou MC; Lee FY; Su TP; Lu CL
Gastroenterology; 2017 Jan; 152(1):134-141. PubMed ID: 27639806
[TBL] [Abstract][Full Text] [Related]
6. Proton pump inhibitors and risk of periampullary cancers--A nested case-control study.
Chien LN; Huang YJ; Shao YH; Chang CJ; Chuang MT; Chiou HY; Yen Y
Int J Cancer; 2016 Mar; 138(6):1401-9. PubMed ID: 26488896
[TBL] [Abstract][Full Text] [Related]
7. Use of proton pump inhibitors is associated with fractures in young adults: a population-based study.
Freedberg DE; Haynes K; Denburg MR; Zemel BS; Leonard MB; Abrams JA; Yang YX
Osteoporos Int; 2015 Oct; 26(10):2501-7. PubMed ID: 25986385
[TBL] [Abstract][Full Text] [Related]
8. Use of Proton Pump Inhibitors and the Risk of Listeriosis: A Nationwide Registry-based Case-Control Study.
Kvistholm Jensen A; Simonsen J; Ethelberg S
Clin Infect Dis; 2017 Apr; 64(7):845-851. PubMed ID: 28013257
[TBL] [Abstract][Full Text] [Related]
9. Is use of a long-term proton pump inhibitor or histamine-2 receptor antagonist a risk factor for iron-deficiency anaemia in Taiwan? A neglected clinical drug-drug interaction.
Wu YT; Lu YT; Chu CY; Chao HJ; Kuo LN; Cheng KJ; Chen HY
Fam Pract; 2023 Sep; ():. PubMed ID: 37756627
[TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitor-related headaches: a nationwide population-based case-crossover study in Taiwan.
Liang JF; Chen YT; Fuh JL; Li SY; Chen TJ; Tang CH; Wang SJ
Cephalalgia; 2015 Mar; 35(3):203-10. PubMed ID: 24853165
[TBL] [Abstract][Full Text] [Related]
11. Using proton pump inhibitors correlates with an increased risk of chronic kidney disease: a nationwide database-derived case-controlled study.
Hung SC; Liao KF; Hung HC; Lin CL; Lai SW; Lee PC; Hung SR
Fam Pract; 2018 Mar; 35(2):166-171. PubMed ID: 29045621
[TBL] [Abstract][Full Text] [Related]
12. Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study.
Dublin S; Walker RL; Jackson ML; Nelson JC; Weiss NS; Jackson LA
Pharmacoepidemiol Drug Saf; 2010 Aug; 19(8):792-802. PubMed ID: 20623507
[TBL] [Abstract][Full Text] [Related]
13. Proton Pump Inhibitors Are Associated with Increased Risk of Psoriasis: A Nationwide Nested Case-Control Study.
Li CY; Dai YX; Chang YT; Bai YM; Tsai SJ; Chen TJ; Chen MH
Dermatology; 2021; 237(6):884-890. PubMed ID: 34474411
[TBL] [Abstract][Full Text] [Related]
14. Proton-pump inhibitors are associated with an increased risk of asthma: A nationwide nested case-control study.
Wang WT; Li CY; Chang YT; Bai YM; Tsai SJ; Chen TJ; Chiou SH; Chen MH
Allergy Asthma Proc; 2023 Sep; 44(5):345-353. PubMed ID: 37641222
[No Abstract] [Full Text] [Related]
15. Use of proton pump inhibitors and risk of ischemic events in the general population.
Casula M; Scotti L; Galimberti F; Mozzanica F; Tragni E; Corrao G; Catapano AL
Atherosclerosis; 2018 Oct; 277():123-129. PubMed ID: 30212680
[TBL] [Abstract][Full Text] [Related]
16. Proton pump inhibitor use represents an independent risk factor for myocardial infarction.
Shih CJ; Chen YT; Ou SM; Li SY; Chen TJ; Wang SJ
Int J Cardiol; 2014 Nov; 177(1):292-7. PubMed ID: 25499395
[TBL] [Abstract][Full Text] [Related]
17. Association of Proton Pump Inhibitors Usage with Risk of Pneumonia in Dementia Patients.
Ho SW; Teng YH; Yang SF; Yeh HW; Wang YH; Chou MC; Yeh CB
J Am Geriatr Soc; 2017 Jul; 65(7):1441-1447. PubMed ID: 28321840
[TBL] [Abstract][Full Text] [Related]
18. Negative Association of Proton Pump Inhibitors With Subsequent Development of Breast Cancer: A Nationwide Population-Based Study.
Chen CH; Lee CZ; Lin YC; Kao LT; Lin HC
J Clin Pharmacol; 2019 Mar; 59(3):350-355. PubMed ID: 30329162
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular and gastrointestinal events of three antiplatelet therapies: clopidogrel, clopidogrel plus proton-pump inhibitors, and aspirin plus proton-pump inhibitors in patients with previous gastrointestinal bleeding.
Tsai YW; Wen YW; Huang WF; Chen PF; Kuo KN; Hsiao FY
J Gastroenterol; 2011 Jan; 46(1):39-45. PubMed ID: 20811753
[TBL] [Abstract][Full Text] [Related]
20. Comparing proton pump inhibitors with histamin-2 receptor blockers regarding the risk of osteoporotic fractures: a nested case-control study of more than 350,000 Korean patients with GERD and peptic ulcer disease.
Park JH; Lee J; Yu SY; Jung JH; Han K; Kim DH; Rhee J
BMC Geriatr; 2020 Oct; 20(1):407. PubMed ID: 33059626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
